GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
11 Jan 2019 04:25 PM
RNS
Director/PDMR Shareholding
02 Jan 2019 01:45 PM
RNS
Total Voting Rights
20 Dec 2018 05:15 PM
RNS
Director/PDMR Shareholding
19 Dec 2018 07:00 AM
RNS
GSK and Pfizer create new Consumer Healthcare JV
14 Dec 2018 01:20 PM
RNS
GSK Commences Tender Offer for TESARO Inc.
12 Dec 2018 04:35 PM
RNS
Director/PDMR Shareholding
04 Dec 2018 10:07 AM
RNS
Director/PDMR Shareholding
03 Dec 2018 02:00 PM
RNS
Total Voting Rights
03 Dec 2018 12:02 PM
RNS
GSK reaches agreement to acquire TESARO
03 Dec 2018 08:35 AM
RNS
GSK to divest Horlicks to Unilever
30 Nov 2018 04:40 PM
RNS
Second Price Monitoring Extn
30 Nov 2018 04:35 PM
RNS
Price Monitoring Extension
29 Nov 2018 03:40 PM
RNS
Director/PDMR Shareholding
29 Nov 2018 11:45 AM
RNS
GSK - Update on Review of Horlicks
27 Nov 2018 03:25 PM
RNS
Block listing Interim Review
22 Nov 2018 01:02 PM
RNS
GSK publishes 2019 Dividend Dates
12 Nov 2018 02:45 PM
RNS
Director/PDMR Shareholding
12 Nov 2018 09:00 AM
RNS
Blocklisting Application
08 Nov 2018 12:43 PM
RNS
Director Declaration
02 Nov 2018 04:15 PM
RNS
Director/PDMR Shareholding
01 Nov 2018 01:40 PM
RNS
Total Voting Rights
31 Oct 2018 02:15 PM
RNS
ViiV positive phIII results with fostemsavir
31 Oct 2018 12:07 PM
RNS
Second Price Monitoring Extn
31 Oct 2018 12:02 PM
RNS
Price Monitoring Extension
31 Oct 2018 12:00 PM
RNS
3rd Quarter Results
30 Oct 2018 02:30 PM
RNS
ViiV: positive data for long-acting injectable
29 Oct 2018 10:00 AM
RNS
ViiV - three-year data for long-acting injectable
18 Oct 2018 04:00 PM
RNS
ViiV submits HIV 2DR regulatory application to FDA
18 Oct 2018 09:34 AM
RNS
Director/PDMR Shareholding
17 Oct 2018 05:56 PM
RNS
Director/PDMR Shareholding
17 Oct 2018 05:50 PM
RNS
Director/PDMR Shareholding
17 Oct 2018 11:30 AM
RNS
Director/PDMR Shareholding
16 Oct 2018 04:53 PM
RNS
Director/PDMR Shareholding
16 Oct 2018 09:30 AM
RNS
Director/PDMR Shareholding
16 Oct 2018 09:30 AM
RNS
Director/PDMR Shareholding
10 Oct 2018 03:30 PM
RNS
Director/PDMR Shareholding
01 Oct 2018 01:58 PM
RNS
Total Voting Rights
27 Sep 2018 04:35 PM
RNS
Director/PDMR Shareholding
21 Sep 2018 12:30 PM
RNS
CHMP recommends expansion of Trelegy COPD label
14 Sep 2018 09:00 AM
RNS
ViiV submits HIV 2DR regulatory application to EMA
12 Sep 2018 05:43 PM
RNS
Director/PDMR Shareholding
10 Sep 2018 08:00 AM
RNS
New analysis on efficacy of anti-IL5 biologics SEA
10 Sep 2018 07:00 AM
RNS
GSK receives CRL from FDA for mepolizumab in COPD
07 Sep 2018 02:24 PM
RNS
Director/PDMR Shareholding
07 Sep 2018 02:18 PM
RNS
Director/PDMR Shareholding
03 Sep 2018 05:00 PM
RNS
Total Voting Rights
30 Aug 2018 05:12 PM
RNS
GSK publishes Q4 2018 Dividend Dates
30 Aug 2018 08:12 AM
RNS
EU approve Nucala in severe asthma in children
24 Aug 2018 10:16 AM
RNS
Director/PDMR Shareholding
15 Aug 2018 07:00 AM
RNS
Positive headline results for ViiV HC ATLAS study

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings